Zions Bancorporation, National Association’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10K Sell
191
-539
-74% -$28.5K ﹤0.01% 916
2026
Q1
$40.3K Sell
730
-107,065
-99% -$5.8M ﹤0.01% 586
2025
Q4
$5.29M Sell
107,795
-25,269
-19% -$1.18M 0.24% 66
2025
Q3
$5.74M Sell
133,064
-50,392
-27% -$1.97M 0.28% 60
2025
Q2
$7.04M Buy
183,456
+183,292
+111,763% +$7M 0.38% 51
2025
Q1
$6.35K Buy
+164
New +$6K ﹤0.01% 722

Other funds holding GSK

Zions Bancorporation, National Association's GSK Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its GSK (GSK) stake by 74% in Q2 2026, selling an estimated $28.5K and leaving 191 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #916.

Zions Bancorporation, National Association first reported a position in GSK in Q1 2025 and has held it in 6 quarters since. The position peaked at $7.04M in Q2 2025. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Zions Bancorporation, National Association held 191 shares of GSK worth $10K as of Q2 2026.
  • Zions Bancorporation, National Association sold 539 GSK shares in Q2 2026, an estimated $28.5K.
  • GSK made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #916 holding.
  • Zions Bancorporation, National Association first reported a position in GSK in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's GSK position peaked at $7.04M in Q2 2025.
  • 439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.